Press release
MHRA to advise on mHealth app initiative for pharmacovigilance
SMi has confirmed that Phil Tregunno, the MHRA’s Signal Management Unit Manager and WEB-RADR Project Lead, will be speaking at the 9th Social Media in the Pharmaceutical Industry conference. The event takes place on the 18th and 19th of January 2017 in London.
More companies continue to improve initiatives for pharmacovigilance. Recently, the MHRA ran a social media campaign to report suspected side effects for medicines. In line with this, they have partnered with a consortium of world-leading experts from industry, regulatory agencies, and academia to lead the WEB-RADR project.
WEB-RADR is an initiative that seeks to utilise social media and emerging technologies for pharmacovigilance purposes. Phil’s presentation at the conference will give an overview of the project, highlighting updates on the apps they are developing to detect and to report adverse drug reactions as well as ethical guidance and appropriate use.
Phil joins a speaker line-up of senior healthcare marketers and brand managers who will lead presentations and workshops that will provide insights on digital health and social media topics such as social listening, creating web content, digital analytics, patient advocacy, mobile apps, plus much more.
For more updates on the conference, follow SMi Group on @smipharm and join the conversation using #pharmasocialmedia on Twitter.
Social Media in the Pharmaceutical Industry
18 & 19 January 2017
Holiday Inn Kensington Forum, London, UK
http://www.social-media-pharma.com/openPR
---end ---
Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Matthew Apps at mapps@smi-online.co.uk. For media queries please contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
1 Westminster Bridge Road, SE1 7XW
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MHRA to advise on mHealth app initiative for pharmacovigilance here
News-ID: 382902 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for MHRA
MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conferenc …
SMi Reports: Industry leaders MHRA, Pfizer, Autolus, Tusk Therapeutics, KCL, Boehringer Ingelheim and more are amongst the latest organisations to register for Immuno-Oncology 2018 (http://www.immuno-oncology-conference.com/openpr)
There’s just 2 weeks until SMi’s Immuno-Oncology conference commences in London on the 26th and 27th September. With limited places left, interested attendees are urged to book soon to avoid missing out on joining an international gathering of immuno-therapy experts at this highly-anticipated conference.
Recent Confirmed Attendees…
Talks from the MHRA, Innovate UK, Plasticell and more
The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike. The growing time-to-market, the rising costs in development of novel medicines, as well as the more basic drive to be ‘ahead of the game’, forces the industry and the legislators to rethink basic postulates of drug development.
The global regulatory environment is undergoing major reshape, allowing patients early access…
MHRA & FDA to explore In Vitro Diagnostics regulations in the EU & USA
The 3rd In Vitro Diagnostics conference for SMi Group will take place in London on the 14th & 15th June 2017.
Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.
Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017…
Attendee List Released for Superbugs 2017 Featuring FDA, GSK, MHRA, Merck and Ab …
With just 4 weeks to go, an attendee list featuring an international audience of AMR experts and scientific pioneers has been released ahead of SMi's long running 19th annual summit on Superbugs & Superdrugs.
The industry calendar highlight on antibiotic resistance will provide a platform for attendee's to network, exchange novel solutions and consolidate current strategy.
Notable sessions on the agenda include:
1. Guidance on common governing pitfalls presented by the FDA.
2. Strategies to…
Attendee List Released Ahead of RNA Therapeutics Industry Summit Featuring MHRA, …
SMi Group have released an attendee list two weeks ahead of the 8th annual conference on RNA Therapeutics which is set to take place in Central London on 22nd & 23rd February.
This year’s show has attracted a truly global audience of scientific pioneers and senior industry thought leaders involved in targeted drug delivery systems from Australia, Belgium, Denmark, Germany, Ireland, Israel, Italy, Japan, Netherlands, Switzerland, Ukraine, United Kingdom and USA.…
Pharma Cold Chain Distribution Updates from MHRA, IATA, GSK, Teva, J&J, World Co …
SMi Group reports (2016.11.10– London, UK): World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016.
Over the last 24 months, we have witnessed market growth and new logistics hubs established around the globe by forwarders and distributors, in order to service and support a more round-the-clock global network for pharmaceutical product supply. Nonetheless, challenges remain with the increasingly fragile biologics…
